Skip to main content

Table 1 General information (n)

From: Clinical analysis of 48 cases of malignant superior vena cava syndrome

 

Group 1

Group 2

Group 3

Group 4

Gender

 Male/female

4/6

5/3

18/4

7/1

Histologic type

 SCLC

5

4

9

2

 NSCLC

3

2

8

2

 NHL

0

0

2

0

 Others

2

2

3

4

  1. Others include thymoma, mediastinal sarcoma, and mediastinal lung small cell carcinoma. Group 1 radiotherapy group, Group 2 chemotherapy group, Group 3 combined radiotherapy and chemotherapy group, Group 4 comprehensive treatment group, SCLC small cell lung cancer, NSCLC non-small cell lung cancer, NHL non-Hodgkin’s lymphoma